Literature DB >> 33743659

Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative study.

Agatha K Bula1, Kendra Hatfield-Timajchy2, John Chapola3, L Chinula3,4, Stacey A Hurst2, Athena P Kourtis2, J H Tang4.   

Abstract

BACKGROUND: Although many countries have been promoting hormonal contraceptives to prevent unintended pregnancy and condom use to prevent HIV transmission, little is known about how women targeted by these messages have interpreted and internalized them. We describe HIV-positive and negative women's understanding of the benefits of contraception and condoms and their motivations to use them.
METHODS: This is a qualitative sub-study from a clinical trial evaluating the effects of progestin contraception on HIV-positive and negative women aged 18-45 years randomly assigned to depot medroxyprogesterone acetate (DMPA) injection or levonorgestrel (LNG) implant. We purposively recruited 41 women to participate in in-depth interviews (IDIs) and focus group discussions (FGDs) after randomization into the main study. We conducted a total of 30 IDIs and 6 FGDs comprised of 4-7 women (N = 32). All women were counselled about potential risks for HIV acquisition/transmission with progestin-only contraception, drug-drug interactions between the implant and efavirenz-based ART, and the need to use condoms with their assigned contraceptive to help prevent pregnancy and HIV acquisition and transmission.
RESULTS: All women understood that HIV is transmitted through unprotected sex and that HIV transmission can be prevented through condom use but not DMPA injection or LNG implant use. Nearly all HIV-positive women knew or suspected that their partners were also HIV-positive and were most interested in using condoms to prevent infection with a drug-resistant HIV strain to keep their HIV viral load low. Almost all reported that their partners agreed to condom use, but few used them consistently. Most women believed that condoms were effective at preventing both HIV and pregnancy if used consistently. Nearly all women considered contraception and condom use as important in preventing unintended pregnancy and HIV because partner disclosure of HIV status is low.
CONCLUSION: Our results showed that both HIV-positive and negative women understood modes of HIV transmission and prevention and were aware that hormonal contraceptives are only effective for preventing pregnancy and not HIV. Although both HIV-negative and positive women were motivated to use condoms to prevent both HIV acquisition and infection with other HIV strains respectively, they all faced challenges from their partners in using condoms consistently.

Entities:  

Keywords:  Condom use; Contraceptive use; Depot medroxyprogesterone acetate; Levonorgestrel implant; Malawi; Motivation

Mesh:

Substances:

Year:  2021        PMID: 33743659      PMCID: PMC7981805          DOI: 10.1186/s12905-021-01236-1

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  32 in total

Review 1.  Progress in HIV vaccine development.

Authors:  Denise C Hsu; Robert J O'Connell
Journal:  Hum Vaccin Immunother       Date:  2017-03-10       Impact factor: 3.452

2.  High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.

Authors:  Sheree R Schwartz; Shruti H Mehta; Taha E Taha; Helen V Rees; Francois Venter; Vivian Black
Journal:  AIDS Behav       Date:  2012-01

3.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

4.  Marital Aspirations, Sexual Behaviors, and HIV/AIDS in Rural Malawi.

Authors:  Shelley Clark; Michelle Poulin; Hans-Peter Kohler
Journal:  J Marriage Fam       Date:  2009-05-01

5.  Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.

Authors:  Jennifer H Tai; Mercy A Udoji; Gema Barkanic; Daniel W Byrne; Peter F Rebeiro; Beverly R Byram; Asghar Kheshti; Justine D Carter; Cornelia R Graves; Stephen P Raffanti; Timothy R Sterling
Journal:  J Infect Dis       Date:  2007-08-29       Impact factor: 5.226

6.  HIV and maternal mortality.

Authors:  Eva Lathrop; Denise J Jamieson; Isabella Danel
Journal:  Int J Gynaecol Obstet       Date:  2014-07-17       Impact factor: 3.561

7.  Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.

Authors:  Jared M Baeten; Deborah Donnell; Nelly R Mugo; Patrick Ndase; Katherine K Thomas; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Lara Kidoguchi; Robert W Coombs; Craig Hendrix; Mark A Marzinke; Lisa Frenkel; Jessica E Haberer; David Bangsberg; Connie Celum
Journal:  Lancet Infect Dis       Date:  2014-10-07       Impact factor: 25.071

8.  HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.

Authors: 
Journal:  Lancet       Date:  2019-06-13       Impact factor: 79.321

9.  Pregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada.

Authors:  Kate Salters; Mona Loutfy; Alexandra de Pokomandy; Deborah Money; Neora Pick; Lu Wang; Shahab Jabbari; Allison Carter; Kath Webster; Tracey Conway; Daniele Dubuc; Nadia O'Brien; Karene Proulx-Boucher; Angela Kaida
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

10.  Factors associated with condom use among men and women living with HIV in Lilongwe, Malawi: a cross-sectional study.

Authors:  Lisa B Haddad; Jennifer H Tang; Jamie Krashin; Wingston Ng'ambi; Hannock Tweya; Bernadette Samala; Jane Chiwoko; Thomas Chaweza; Mina C Hosseinipour; Eva Lathrop; Denise J Jamieson; Sam Phiri
Journal:  BMJ Sex Reprod Health       Date:  2017-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.